|
⚲
|
| Keyboard |
| Breedlove Mark H
✚
|
|
|---|---|
| CIK # | 0001876529 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001876529] | |
| 4 | [0001876529] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cognition Therapeutics Inc | |
| Breedlove Mark H |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 36,714 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 225,281 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 93,296 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 4,354 | $0.03 | 131 |
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Sell | 11.74 | $12.00 | 141 |
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 44,806 | ||
|
Cognition Therapeutics Inc CGTX
Warrant (Right to Buy) · derivative
|
2021-10-13 | Option exercise | 4,354 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series B-1 Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 301,978 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series B Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 826,278 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series A-2 Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 118,835 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series A-1 Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 144,928 | $0.00 |